IDEA AG, Frankfurter Ring 193a, 80807 Munich, Germany.
Pharm Res. 2011 Sep;28(9):2204-22. doi: 10.1007/s11095-011-0448-z. Epub 2011 May 17.
To apply UV/Vis spectrometry for characterization of submicroscopic drug carriers, such as nanoparticles and lipid vesicles.
We first investigated theoretically, within the framework of the Rayleigh-Gans-Debye approximation (RGDA), parameters affecting turbidity spectrum, τ(λ), of nanosized light scatterers. We then analyzed, within the framework of the RGDA, experimental turbidity spectra (λ = 400-600 nm) of extruded unilamellar vesicle (70 nm ≤ 2r ≤ 110 nm) suspensions to derive vesicle size, using dynamic light scattering results for comparison. We similarly studied the preparations polydispersity and lamellarity and monitored vesicle size changes.
Turbidimetry suffices for accurate, fast, and viscosity-independent characterization of submicroscopic particles. Analysis of turbidity spectra, or more precisely wavelength exponent spectra (derivatives of logarithmic turbidity spectra), yielded similar average radii (r = 54.2 ± 0.2 nm; 46.0 ± 0.2 nm; 35.5 ± 0.1 nm) as dynamic light scattering (r = 55.9 ± 1.5 nm; 46.1 ± 0.4 nm; 36.1 ± 0.4 nm). Both methods also revealed similar suspension polydispersity and cholate-induced vesicle size changes in a few nanometer range.
Despite its experimental simplicity, the widely accessible turbidimetric method provides accurate size values and is suitable for (continuous) monitoring size stability, or sameness, of submicroscopic drug carriers.
应用紫外/可见分光光度法对亚微观药物载体(如纳米颗粒和脂质体)进行特征分析。
我们首先在瑞利-甘斯-德拜近似(RGDA)框架内,从理论上研究了影响纳米光散射体浊度谱τ(λ)的参数。然后,我们在 RGDA 框架内分析了挤出单层囊泡(70nm≤2r≤110nm)悬浮液的实验浊度谱(λ=400-600nm),并与动态光散射结果进行比较,得出囊泡尺寸。我们同样研究了制剂的多分散性和层状结构,并监测了囊泡尺寸的变化。
比浊法足以准确、快速、且不受粘度影响地对亚微观颗粒进行特征分析。浊度光谱分析,或者更确切地说是波长指数光谱(对数浊度光谱的导数),得出了相似的平均半径(r=54.2±0.2nm;46.0±0.2nm;35.5±0.1nm),与动态光散射结果(r=55.9±1.5nm;46.1±0.4nm;36.1±0.4nm)相似。两种方法都揭示了相似的悬浮液多分散性和胆酸钠诱导的囊泡尺寸在几纳米范围内的变化。
尽管比浊法实验简单,但它提供了准确的尺寸值,适用于(连续)监测亚微观药物载体的尺寸稳定性或相同性。